image
Energy - Oil & Gas Midstream - NYSE - US
$ 52.86
0.724 %
$ 1.8 B
Market Cap
15.97
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 19, 2025.

The intrinsic value of one GLP stock under the worst case scenario is HIDDEN Compared to the current market price of 52.9 USD, Global Partners LP is HIDDEN

This DCF valuation model was last updated on Jan, 19, 2025.

The intrinsic value of one GLP stock under the base case scenario is HIDDEN Compared to the current market price of 52.9 USD, Global Partners LP is HIDDEN

This DCF valuation model was last updated on Jan, 19, 2025.

The intrinsic value of one GLP stock under the best case scenario is HIDDEN Compared to the current market price of 52.9 USD, Global Partners LP is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
16.5 B REVENUE
-12.64%
244 M OPERATING INCOME
-47.04%
143 M NET INCOME
-60.63%
512 M OPERATING CASH FLOW
6.76%
-492 M INVESTING CASH FLOW
-108.47%
-4.46 M FINANCING CASH FLOW
98.22%
8.56 B REVENUE
94.08%
83.5 M OPERATING INCOME
-0.96%
45.9 M NET INCOME
8.44%
123 M OPERATING CASH FLOW
281.62%
1.8 M INVESTING CASH FLOW
100.78%
-118 M FINANCING CASH FLOW
-79.98%
Balance Sheet Global Partners LP
image
Current Assets 1.1 B
Cash & Short-Term Investments 19.6 M
Receivables 560 M
Other Current Assets 518 M
Non-Current Assets 2.43 B
Long-Term Investments 94.4 M
PP&E 1.77 B
Other Non-Current Assets 574 M
Current Liabilities 983 M
Accounts Payable 649 M
Short-Term Debt 76.7 M
Other Current Liabilities 257 M
Non-Current Liabilities 1.66 B
Long-Term Debt 1.46 B
Other Non-Current Liabilities 201 M
EFFICIENCY
Earnings Waterfall Global Partners LP
image
Revenue 16.5 B
Cost Of Revenue 16 B
Gross Profit 514 M
Operating Expenses 266 M
Operating Income 244 M
Other Expenses 101 M
Net Income 143 M
RATIOS
3.12% GROSS MARGIN
3.12%
1.48% OPERATING MARGIN
1.48%
0.92% NET MARGIN
0.92%
19.09% ROE
19.09%
4.43% ROA
4.43%
11.94% ROIC
11.94%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Global Partners LP
image
Net Income 143 M
Depreciation & Amortization 110 M
Capital Expenditures -402 M
Stock-Based Compensation 10.6 M
Change in Working Capital 233 M
Others -43.2 M
Free Cash Flow 110 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Global Partners LP
image
GLP has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
1.89% DIVIDEND YIELD
0.73 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Global Partners LP
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
3.01 M USD 1
0-3 MONTHS
3.48 M USD 1
3-6 MONTHS
7.9 M USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
3 weeks ago
Dec 24, 2024
Bought 148 K USD
Global GP LLC
other: General Partner
+ 3000
49.39 USD
3 weeks ago
Dec 23, 2024
Bought 142 K USD
Global GP LLC
other: General Partner
+ 3000
47.35 USD
1 month ago
Dec 20, 2024
Bought 146 K USD
Global GP LLC
other: General Partner
+ 3000
48.67 USD
1 month ago
Dec 19, 2024
Bought 143 K USD
Global GP LLC
other: General Partner
+ 3000
47.76 USD
1 month ago
Dec 18, 2024
Bought 147 K USD
Global GP LLC
other: General Partner
+ 3000
48.84 USD
1 month ago
Dec 17, 2024
Bought 99.4 K USD
Global GP LLC
other: General Partner
+ 2000
49.7 USD
1 month ago
Dec 16, 2024
Bought 104 K USD
Global GP LLC
other: General Partner
+ 2000
52.17 USD
1 month ago
Dec 12, 2024
Bought 275 K USD
Global GP LLC
other: General Partner
+ 5000
55.05 USD
1 month ago
Dec 09, 2024
Bought 281 K USD
Global GP LLC
other: General Partner
+ 5000
56.17 USD
1 month ago
Nov 25, 2024
Bought 263 K USD
Global GP LLC
other: General Partner
+ 5000
52.66 USD
1 month ago
Nov 20, 2024
Bought 254 K USD
Global GP LLC
other: General Partner
+ 5000
50.9 USD
2 months ago
Nov 19, 2024
Bought 259 K USD
Global GP LLC
other: General Partner
+ 5000
51.81 USD
2 months ago
Nov 18, 2024
Bought 254 K USD
Global GP LLC
other: General Partner
+ 5000
50.76 USD
2 months ago
Nov 15, 2024
Bought 248 K USD
Global GP LLC
other: General Partner
+ 5000
49.51 USD
2 months ago
Nov 14, 2024
Bought 246 K USD
Global GP LLC
other: General Partner
+ 5000
49.25 USD
4 months ago
Sep 20, 2024
Bought 99.5 K USD
Global GP LLC
other: General Partner
+ 2226
44.71 USD
4 months ago
Sep 18, 2024
Bought 220 K USD
Global GP LLC
other: General Partner
+ 5000
44.02 USD
4 months ago
Sep 17, 2024
Bought 91.6 K USD
Global GP LLC
other: General Partner
+ 2100
43.6 USD
4 months ago
Sep 16, 2024
Bought 215 K USD
Global GP LLC
other: General Partner
+ 5000
43.07 USD
4 months ago
Sep 13, 2024
Bought 214 K USD
Global GP LLC
other: General Partner
+ 5000
42.84 USD
4 months ago
Sep 11, 2024
Bought 219 K USD
Global GP LLC
other: General Partner
+ 5000
43.85 USD
4 months ago
Sep 11, 2024
Bought 219 K USD
Global GP LLC
other: General Partner
+ 5000
43.85 USD
4 months ago
Sep 10, 2024
Bought 207 K USD
Global GP LLC
other: General Partner
+ 4800
43.17 USD
4 months ago
Sep 05, 2024
Bought 212 K USD
Global GP LLC
other: General Partner
+ 5000
42.4 USD
4 months ago
Sep 04, 2024
Bought 210 K USD
Global GP LLC
other: General Partner
+ 5000
42.06 USD
4 months ago
Sep 03, 2024
Bought 422 K USD
Global GP LLC
other: General Partner
+ 10000
42.21 USD
4 months ago
Aug 30, 2024
Bought 227 K USD
Global GP LLC
other: General Partner
+ 5000
45.34 USD
4 months ago
Aug 29, 2024
Bought 338 K USD
Global GP LLC
other: General Partner
+ 7500
45.08 USD
4 months ago
Aug 28, 2024
Bought 215 K USD
Global GP LLC
other: General Partner
+ 5000
42.98 USD
4 months ago
Aug 27, 2024
Bought 213 K USD
Global GP LLC
other: General Partner
+ 5000
42.67 USD
5 months ago
Aug 19, 2024
Bought 101 K USD
Global GP LLC
other: General Partner
+ 2400
41.88 USD
5 months ago
Aug 15, 2024
Bought 52.6 K USD
Global GP LLC
other: General Partner
+ 1300
40.49 USD
7 months ago
Jun 20, 2024
Bought 457 K USD
Global GP LLC
other: General Partner
+ 10000
45.68 USD
7 months ago
Jun 18, 2024
Bought 229 K USD
Global GP LLC
other: General Partner
+ 5000
45.71 USD
7 months ago
Jun 17, 2024
Bought 474 K USD
Global GP LLC
other: General Partner
+ 10000
47.37 USD
7 months ago
Jun 10, 2024
Bought 502 K USD
Global GP LLC
other: General Partner
+ 10000
50.23 USD
7 months ago
May 31, 2024
Bought 476 K USD
Global GP LLC
other: General Partner
+ 10000
47.61 USD
7 months ago
May 30, 2024
Bought 467 K USD
Global GP LLC
other: General Partner
+ 10000
46.69 USD
7 months ago
May 29, 2024
Bought 461 K USD
Global GP LLC
other: General Partner
+ 10000
46.14 USD
7 months ago
May 28, 2024
Bought 446 K USD
Global GP LLC
other: General Partner
+ 10000
44.63 USD
7 months ago
May 24, 2024
Bought 449 K USD
Global GP LLC
other: General Partner
+ 10000
44.92 USD
7 months ago
May 23, 2024
Bought 446 K USD
Global GP LLC
other: General Partner
+ 10000
44.62 USD
7 months ago
May 22, 2024
Bought 435 K USD
Global GP LLC
other: General Partner
+ 10000
43.49 USD
8 months ago
May 21, 2024
Bought 454 K USD
Global GP LLC
other: General Partner
+ 10000
45.37 USD
8 months ago
May 20, 2024
Bought 450 K USD
Global GP LLC
other: General Partner
+ 10000
44.96 USD
8 months ago
May 17, 2024
Bought 440 K USD
Global GP LLC
other: General Partner
+ 10000
44.05 USD
8 months ago
May 16, 2024
Bought 436 K USD
Global GP LLC
other: General Partner
+ 10000
43.56 USD
8 months ago
May 15, 2024
Bought 433 K USD
Global GP LLC
other: General Partner
+ 10000
43.29 USD
8 months ago
May 14, 2024
Bought 414 K USD
Global GP LLC
other: General Partner
+ 10000
41.43 USD
8 months ago
May 13, 2024
Bought 427 K USD
Global GP LLC
other: General Partner
+ 10000
42.66 USD
1 year ago
Dec 08, 2023
Bought 302 K USD
Global GP LLC
+ 8000
37.78 USD
1 year ago
Nov 28, 2023
Bought 350 K USD
Global GP LLC
+ 10000
34.99 USD
1 year ago
Nov 27, 2023
Bought 341 K USD
Global GP LLC
+ 10000
34.1 USD
1 year ago
Nov 21, 2023
Bought 343 K USD
Global GP LLC
+ 10000
34.26 USD
1 year ago
Nov 20, 2023
Bought 341 K USD
Global GP LLC
+ 10000
34.11 USD
1 year ago
Nov 16, 2023
Bought 333 K USD
Global GP LLC
+ 10000
33.34 USD
1 year ago
Nov 15, 2023
Bought 505 K USD
Global GP LLC
+ 15000
33.64 USD
1 year ago
Nov 14, 2023
Bought 329 K USD
Global GP LLC
+ 10000
32.88 USD
1 year ago
Sep 25, 2023
Bought 13.5 K USD
Global GP LLC
+ 415
32.49 USD
1 year ago
Sep 21, 2023
Bought 330 K USD
Global GP LLC
+ 10000
33 USD
1 year ago
Sep 19, 2023
Bought 331 K USD
Global GP LLC
+ 10000
33.12 USD
1 year ago
Aug 09, 2023
Bought 24.8 K USD
Kelly Clare McGrory
Director
+ 800
30.99 USD
1 year ago
May 17, 2023
Sell 12.4 K USD
Pereira Jaime
Director
- 400
31 USD
2 years ago
Nov 25, 2022
Bought 67.5 K USD
Global GP LLC
Director
+ 2100
32.13 USD
2 years ago
Nov 23, 2022
Bought 63 K USD
Global GP LLC
Director
+ 2000
31.5 USD
2 years ago
Nov 21, 2022
Bought 90.6 K USD
Global GP LLC
Director
+ 3000
30.2 USD
2 years ago
Nov 18, 2022
Bought 78.3 K USD
Global GP LLC
Director
+ 2584
30.3 USD
2 years ago
Nov 16, 2022
Bought 31.2 K USD
Global GP LLC
Director
+ 1000
31.2 USD
2 years ago
Sep 16, 2022
Bought 28.4 K USD
Pereira Jaime
Director
+ 1000
28.45 USD
2 years ago
Aug 25, 2022
Bought 27.8 K USD
Pereira Jaime
Director
+ 1000
27.85 USD
2 years ago
May 19, 2022
Sell 60.6 K USD
Langhorn Jeremy
Chief Human Resources Officer
- 2191
27.67 USD
2 years ago
Jun 23, 2022
Bought 115 K USD
Global GP LLC
director:
+ 5000
23.01 USD
2 years ago
Jun 23, 2022
Bought 120 K USD
Global GP LLC
other: General Partner
+ 5433
22.05 USD
2 years ago
Jun 22, 2022
Bought 173 K USD
Global GP LLC
other: General Partner
+ 7500
23.01 USD
2 years ago
Jun 21, 2022
Bought 65.3 K USD
Global GP LLC
director:
+ 2900
22.51 USD
2 years ago
Jun 17, 2022
Bought 134 K USD
Global GP LLC
other: General Partner
+ 6545
20.46 USD
2 years ago
Jun 16, 2022
Bought 107 K USD
Global GP LLC
other: General Partner
+ 5000
21.37 USD
2 years ago
Jun 15, 2022
Bought 241 K USD
Global GP LLC
director:
+ 10000
24.09 USD
2 years ago
May 31, 2022
Bought 541 K USD
Global GP LLC
director:
+ 18119
29.85 USD
2 years ago
May 31, 2022
Bought 445 K USD
Global GP LLC
other: General Partner
+ 15075
29.55 USD
2 years ago
May 24, 2022
Bought 424 K USD
Global GP LLC
director:
+ 14786
28.66 USD
2 years ago
May 24, 2022
Bought 195 K USD
Global GP LLC
other: General Partner
+ 6940
28.08 USD
3 years ago
Jun 18, 2021
Bought 239 K USD
Global GP LLC
+ 9120
26.18 USD
3 years ago
Jun 17, 2021
Bought 544 K USD
Global GP LLC
+ 20653
26.35 USD
3 years ago
Jun 16, 2021
Bought 436 K USD
Global GP LLC
+ 16224
26.9 USD
3 years ago
Jun 15, 2021
Bought 143 K USD
Global GP LLC
+ 5412
26.4 USD
3 years ago
Jun 14, 2021
Bought 666 K USD
Global GP LLC
+ 25000
26.62 USD
3 years ago
Jun 09, 2021
Bought 570 K USD
Global GP LLC
+ 20974
27.18 USD
3 years ago
Jun 07, 2021
Bought 630 K USD
Global GP LLC
+ 23551
26.74 USD
3 years ago
Jun 04, 2021
Bought 535 K USD
Global GP LLC
+ 20404
26.2 USD
3 years ago
May 12, 2021
Sell 70.7 K USD
McCool Robert J
Director
- 3000
23.57 USD
4 years ago
Jun 29, 2020
Bought 21.5 K USD
Global GP LLC
+ 2193
9.81 USD
4 years ago
Jun 26, 2020
Bought 267 K USD
Global GP LLC
+ 27807
9.6 USD
4 years ago
Mar 24, 2020
Bought 21.6 K USD
Slifka Richard
director, 10 percent owner:
+ 1800
11.99 USD
4 years ago
Mar 24, 2020
Bought 20.4 K USD
Slifka Andrew P.
Executive Vice President
+ 1700
12 USD
4 years ago
Mar 23, 2020
Bought 14.6 K USD
Slifka Andrew P.
Executive Vice President
+ 1065
13.73 USD
4 years ago
Mar 23, 2020
Bought 2.29 K USD
Slifka Andrew P.
Executive Vice President
+ 200
11.46 USD
4 years ago
Mar 23, 2020
Bought 2.74 K USD
Slifka Andrew P.
Executive Vice President
+ 200
13.72 USD
4 years ago
Mar 19, 2020
Bought 29.6 K USD
McCool Robert J
Director
+ 3000
9.86 USD
4 years ago
Mar 19, 2020
Bought 3.98 K USD
Slifka Eric
President and CEO
+ 370
10.75 USD
4 years ago
Mar 18, 2020
Bought 33.2 K USD
Slifka Eric
President and CEO
+ 3300
10.07 USD
6 years ago
Dec 11, 2018
Sell 45.4 K USD
MCKOWN DAVID K
Director
- 2715
16.71 USD
9 years ago
Dec 24, 2015
Sell 15.1 M USD
Slifka Alfred A
10 percent owner
- 879373
17.2 USD
9 years ago
Sep 14, 2015
Bought 239 K USD
Global GP LLC
+ 7901
30.25 USD
9 years ago
Sep 11, 2015
Bought 361 K USD
Global GP LLC
+ 11788
30.65 USD
9 years ago
Sep 10, 2015
Bought 302 K USD
Global GP LLC
+ 9877
30.57 USD
9 years ago
Sep 09, 2015
Bought 318 K USD
Global GP LLC
+ 10000
31.83 USD
9 years ago
Sep 04, 2015
Bought 109 K USD
Global GP LLC
+ 3400
32.01 USD
9 years ago
Sep 02, 2015
Bought 31.1 K USD
Foster Daphne H.
CFO
+ 1000
31.1 USD
9 years ago
Sep 02, 2015
Bought 31.2 K USD
Foster Daphne H.
CFO
+ 1000
31.25 USD
9 years ago
Sep 03, 2015
Bought 52.7 K USD
Global GP LLC
+ 1646
31.99 USD
9 years ago
Sep 02, 2015
Bought 66 K USD
Global GP LLC
+ 2101
31.41 USD
9 years ago
Aug 13, 2015
Bought 120 K USD
WATCHMAKER KENNETH I
Director
+ 3800
31.6 USD
9 years ago
Mar 23, 2015
Bought 906 K USD
Global GP LLC
+ 23800
38.07 USD
9 years ago
Mar 20, 2015
Bought 789 K USD
Global GP LLC
+ 21000
37.57 USD
9 years ago
Mar 19, 2015
Bought 462 K USD
Global GP LLC
+ 12600
36.66 USD
9 years ago
Mar 18, 2015
Bought 283 K USD
Global GP LLC
+ 7925
35.7 USD
12 years ago
May 31, 2012
Bought 30.2 K USD
WATCHMAKER KENNETH I
Director
+ 1400
21.5799 USD
10 years ago
Dec 24, 2014
Bought 107 K USD
Global GP LLC
Director
+ 3100
34.44 USD
10 years ago
Dec 23, 2014
Bought 337 K USD
Global GP LLC
Director
+ 9643
34.98 USD
10 years ago
Dec 22, 2014
Bought 973 K USD
Global GP LLC
Director
+ 29000
33.55 USD
10 years ago
Dec 19, 2014
Bought 1.37 M USD
Global GP LLC
Director
+ 40000
34.32 USD
10 years ago
Dec 18, 2014
Bought 1.41 M USD
Global GP LLC
Director
+ 40000
35.35 USD
10 years ago
Dec 19, 2014
Bought 1.37 M USD
Global GP LLC
Director
+ 40000
34.32 USD
10 years ago
Dec 18, 2014
Bought 1.41 M USD
Global GP LLC
Director
+ 40000
35.35 USD
10 years ago
Sep 08, 2014
Bought 52 K USD
Global GP LLC
Director
+ 1302
39.92 USD
10 years ago
Aug 15, 2014
Bought 2.03 M USD
Global GP LLC
Director
+ 50007
40.61 USD
10 years ago
Aug 13, 2014
Bought 259 K USD
Global GP LLC
Director
+ 6600
39.22 USD
10 years ago
Aug 12, 2014
Bought 257 K USD
Global GP LLC
Director
+ 6600
38.91 USD
10 years ago
Jun 05, 2014
Bought 229 K USD
Global GP LLC
Director
+ 5600
40.95 USD
10 years ago
Jun 04, 2014
Bought 172 K USD
Global GP LLC
Director
+ 4200
40.84 USD
10 years ago
Jun 03, 2014
Bought 228 K USD
Global GP LLC
Director
+ 5600
40.68 USD
10 years ago
May 30, 2014
Bought 207 K USD
Global GP LLC
Director
+ 5100
40.68 USD
10 years ago
May 28, 2014
Bought 206 K USD
Global GP LLC
Director
+ 5100
40.42 USD
10 years ago
May 27, 2014
Bought 205 K USD
Global GP LLC
Director
+ 5100
40.21 USD
10 years ago
May 23, 2014
Bought 183 K USD
Global GP LLC
Director
+ 4500
40.69 USD
10 years ago
May 21, 2014
Bought 196 K USD
Global GP LLC
Director
+ 4800
40.83 USD
10 years ago
May 20, 2014
Bought 196 K USD
Global GP LLC
Director
+ 4800
40.9 USD
11 years ago
Dec 11, 2013
Bought 259 K USD
Global GP LLC
Director
+ 7500
34.51 USD
11 years ago
Nov 15, 2013
Bought 49.9 K USD
WATCHMAKER KENNETH I
Director
+ 1450
34.44 USD
11 years ago
Aug 22, 2013
Bought 179 K USD
Global GP LLC
Director
+ 5000
35.75 USD
11 years ago
Aug 21, 2013
Bought 700 K USD
Global GP LLC
Director
+ 20000
34.99 USD
11 years ago
Aug 20, 2013
Bought 694 K USD
Global GP LLC
Director
+ 20000
34.69 USD
11 years ago
Aug 19, 2013
Bought 695 K USD
Global GP LLC
Director
+ 20000
34.73 USD
11 years ago
Aug 16, 2013
Bought 574 K USD
Global GP LLC
Director
+ 16600
34.56 USD
11 years ago
Aug 15, 2013
Bought 599 K USD
Global GP LLC
Director
+ 17400
34.43 USD
11 years ago
Aug 14, 2013
Bought 599 K USD
Global GP LLC
Director
+ 17400
34.42 USD
11 years ago
Aug 13, 2013
Bought 288 K USD
Global GP LLC
Director
+ 8941
32.17 USD
12 years ago
Jun 25, 2012
Bought 96.2 K USD
Global GP LLC
Director
+ 4700
20.47 USD
12 years ago
Jun 21, 2012
Bought 206 K USD
Global GP LLC
Director
+ 10000
20.59 USD
12 years ago
Jun 15, 2012
Bought 8.44 K USD
Global GP LLC
Director
+ 400
21.1 USD
12 years ago
Jun 14, 2012
Bought 214 K USD
Global GP LLC
Director
+ 10000
21.39 USD
12 years ago
Jun 04, 2012
Bought 198 K USD
Global GP LLC
Director
+ 9800
20.21 USD
12 years ago
Jun 01, 2012
Bought 233 K USD
Global GP LLC
Director
+ 11031
21.13 USD
12 years ago
May 31, 2012
Bought 147 K USD
Global GP LLC
Director
+ 6900
21.37 USD
12 years ago
May 30, 2012
Bought 58 K USD
Global GP LLC
Director
+ 2700
21.48 USD
12 years ago
May 25, 2012
Bought 87.9 K USD
Global GP LLC
Director
+ 4000
21.98 USD
12 years ago
May 23, 2012
Bought 65.4 K USD
Global GP LLC
Director
+ 3090
21.18 USD
12 years ago
May 21, 2012
Bought 4.23 K USD
Global GP LLC
Director
+ 200
21.13 USD
12 years ago
May 18, 2012
Bought 157 K USD
Global GP LLC
Director
+ 7462
21.08 USD
12 years ago
May 17, 2012
Bought 160 K USD
Global GP LLC
Director
+ 7400
21.56 USD
12 years ago
May 16, 2012
Bought 165 K USD
Global GP LLC
Director
+ 7500
21.97 USD
12 years ago
May 15, 2012
Bought 217 K USD
Global GP LLC
Director
+ 10000
21.72 USD
12 years ago
May 14, 2012
Bought 131 K USD
Global GP LLC
Director
+ 6100
21.45 USD
12 years ago
Mar 01, 2012
Bought 0 USD
Slifka Richard
director, 10 percent owner:
+ 5850000
0 USD
12 years ago
Mar 01, 2012
Bought 0 USD
Slifka Alfred A
director, 10 percent owner:
+ 5850000
0 USD
13 years ago
Sep 09, 2011
Bought 133 K USD
Global GP LLC
Director
+ 6500
20.48 USD
13 years ago
Sep 07, 2011
Bought 92 K USD
Global GP LLC
Director
+ 4600
19.99 USD
13 years ago
Aug 22, 2011
Bought 92.2 K USD
Global GP LLC
Director
+ 5000
18.43 USD
13 years ago
Aug 18, 2011
Bought 190 K USD
Global GP LLC
Director
+ 10000
19.04 USD
13 years ago
May 17, 2011
Bought 54.8 K USD
Global GP LLC
Director
+ 2200
24.9 USD
13 years ago
May 13, 2011
Bought 69.7 K USD
Global GP LLC
Director
+ 2800
24.9 USD
13 years ago
May 12, 2011
Bought 25 K USD
Global GP LLC
Director
+ 1000
25 USD
14 years ago
Nov 22, 2010
Bought 767 K USD
Global GP LLC
Director
+ 29400
26.08 USD
14 years ago
Nov 18, 2010
Bought 83.6 K USD
Global GP LLC
Director
+ 3300
25.34 USD
14 years ago
Nov 17, 2010
Bought 89.4 K USD
WATCHMAKER KENNETH I
Director
+ 3500
25.54 USD
14 years ago
Nov 17, 2010
Bought 30.3 K USD
Global GP LLC
Director
+ 1200
25.22 USD
15 years ago
Dec 10, 2009
Bought 30.2 K USD
Global GP LLC
Director
+ 1300
23.23 USD
15 years ago
Dec 04, 2009
Bought 19 K USD
Global GP LLC
Director
+ 800
23.75 USD
15 years ago
Dec 03, 2009
Bought 142 K USD
Global GP LLC
Director
+ 6000
23.72 USD
15 years ago
Dec 02, 2009
Bought 56.8 K USD
Global GP LLC
Director
+ 2400
23.65 USD
15 years ago
Dec 01, 2009
Bought 7.05 K USD
Global GP LLC
Director
+ 300
23.5 USD
15 years ago
Nov 27, 2009
Bought 21.4 K USD
Global GP LLC
Director
+ 900
23.75 USD
15 years ago
Nov 25, 2009
Bought 7.12 K USD
Global GP LLC
Director
+ 300
23.75 USD
15 years ago
Nov 24, 2009
Bought 16.6 K USD
Global GP LLC
Director
+ 700
23.69 USD
15 years ago
Nov 19, 2009
Bought 71.1 K USD
Global GP LLC
Director
+ 3000
23.71 USD
15 years ago
Nov 16, 2009
Bought 57.5 K USD
Global GP LLC
Director
+ 2500
22.99 USD
15 years ago
Nov 12, 2009
Bought 43.3 K USD
Global GP LLC
Director
+ 1900
22.77 USD
15 years ago
Nov 11, 2009
Bought 18.4 K USD
Global GP LLC
Director
+ 800
23 USD
15 years ago
Sep 10, 2009
Bought 185 K USD
Global GP LLC
Director
+ 7700
24.04 USD
15 years ago
Sep 09, 2009
Bought 13.9 K USD
Global GP LLC
Director
+ 600
23.19 USD
15 years ago
Sep 08, 2009
Bought 146 K USD
Global GP LLC
Director
+ 6400
22.89 USD
15 years ago
Sep 04, 2009
Bought 158 K USD
Global GP LLC
Director
+ 6900
22.85 USD
15 years ago
Sep 03, 2009
Bought 155 K USD
Global GP LLC
Director
+ 6900
22.53 USD
15 years ago
Sep 01, 2009
Bought 26.4 K USD
Global GP LLC
Director
+ 1200
22 USD
15 years ago
Aug 31, 2009
Bought 41.3 K USD
Global GP LLC
Director
+ 1900
21.76 USD
15 years ago
Aug 27, 2009
Bought 106 K USD
Global GP LLC
Director
+ 4800
22.13 USD
15 years ago
Aug 21, 2009
Bought 110 K USD
Global GP LLC
Director
+ 4900
22.42 USD
15 years ago
Aug 20, 2009
Bought 98.9 K USD
Global GP LLC
Director
+ 4500
21.98 USD
15 years ago
Aug 19, 2009
Bought 106 K USD
Global GP LLC
Director
+ 4900
21.63 USD
15 years ago
Aug 18, 2009
Bought 86.6 K USD
Global GP LLC
Director
+ 4000
21.65 USD
15 years ago
Aug 17, 2009
Bought 22.2 K USD
Global GP LLC
Director
+ 1056
21.01 USD
15 years ago
Aug 12, 2009
Bought 54 K USD
Global GP LLC
Director
+ 2500
21.59 USD
15 years ago
Aug 11, 2009
Bought 54 K USD
Global GP LLC
Director
+ 2535
21.3 USD
15 years ago
Aug 14, 2009
Bought 85.3 K USD
Global GP LLC
Director
+ 3900
21.88 USD
15 years ago
Aug 13, 2009
Bought 103 K USD
Global GP LLC
Director
+ 4700
21.98 USD
15 years ago
Aug 12, 2009
Bought 54 K USD
Global GP LLC
Director
+ 2500
21.59 USD
15 years ago
Aug 11, 2009
Bought 54 K USD
Global GP LLC
Director
+ 2535
21.3 USD
15 years ago
Jul 10, 2009
Bought 52.3 K USD
Global GP LLC
Director
+ 2969
17.6 USD
15 years ago
Jul 09, 2009
Bought 28.6 K USD
Global GP LLC
Director
+ 1612
17.73 USD
15 years ago
Jul 08, 2009
Bought 178 K USD
Global GP LLC
Director
+ 10044
17.75 USD
15 years ago
Jul 07, 2009
Bought 139 K USD
Global GP LLC
Director
+ 7698
18.04 USD
15 years ago
Jul 06, 2009
Bought 62.7 K USD
Global GP LLC
Director
+ 3402
18.43 USD
15 years ago
Jul 02, 2009
Bought 1.8 K USD
Global GP LLC
Director
+ 100
18 USD
15 years ago
Jul 01, 2009
Bought 39.5 K USD
Global GP LLC
Director
+ 2200
17.97 USD
15 years ago
Jun 30, 2009
Bought 74.6 K USD
Global GP LLC
Director
+ 4000
18.64 USD
15 years ago
Jun 29, 2009
Bought 38 K USD
Global GP LLC
Director
+ 2000
18.98 USD
15 years ago
Jun 24, 2009
Bought 190 K USD
Global GP LLC
Director
+ 10301
18.48 USD
15 years ago
Jun 23, 2009
Bought 192 K USD
Global GP LLC
Director
+ 10345
18.53 USD
15 years ago
Jun 22, 2009
Bought 154 K USD
Global GP LLC
Director
+ 8275
18.61 USD
15 years ago
Jun 18, 2009
Bought 75.7 K USD
Global GP LLC
Director
+ 4144
18.26 USD
15 years ago
Jun 18, 2009
Bought 59.5 K USD
Global GP LLC
Director
+ 3400
17.5 USD
15 years ago
Jun 17, 2009
Bought 25.5 K USD
Global GP LLC
Director
+ 1400
18.19 USD
15 years ago
Jun 17, 2009
Bought 159 K USD
Global GP LLC
Director
+ 9157
17.41 USD
15 years ago
Jun 16, 2009
Bought 11.7 K USD
Global GP LLC
Director
+ 600
19.53 USD
15 years ago
Jun 16, 2009
Bought 118 K USD
Global GP LLC
Director
+ 6294
18.81 USD
15 years ago
Jun 11, 2009
Bought 44.6 K USD
Global GP LLC
Director
+ 2500
17.84 USD
15 years ago
Jun 10, 2009
Bought 47 K USD
Global GP LLC
Director
+ 2611
18 USD
15 years ago
Jun 03, 2009
Bought 86.6 K USD
Global GP LLC
Director
+ 4848
17.86 USD
15 years ago
Jun 02, 2009
Bought 37.7 K USD
Global GP LLC
Director
+ 2100
17.94 USD
15 years ago
Jun 02, 2009
Bought 87.1 K USD
Global GP LLC
Director
+ 5000
17.42 USD
16 years ago
Nov 28, 2008
Bought 41.5 K USD
McCool Robert J
Director
+ 4000
10.37 USD
17 years ago
Aug 16, 2007
Bought 5.35 K USD
Slifka Eric
President & CEO
+ 200
26.75 USD
17 years ago
Aug 16, 2007
Bought 5.34 K USD
Slifka Eric
President & CEO
+ 200
26.72 USD
17 years ago
Aug 16, 2007
Bought 2.67 K USD
Slifka Eric
President & CEO
+ 100
26.68 USD
17 years ago
Aug 16, 2007
Bought 10.6 K USD
Slifka Eric
President & CEO
+ 400
26.44 USD
17 years ago
Aug 16, 2007
Bought 5.29 K USD
Slifka Eric
President & CEO
+ 200
26.43 USD
17 years ago
Aug 16, 2007
Bought 2.64 K USD
Slifka Eric
President & CEO
+ 100
26.36 USD
17 years ago
Aug 16, 2007
Bought 7.9 K USD
Slifka Eric
President & CEO
+ 300
26.35 USD
17 years ago
Aug 16, 2007
Bought 2.63 K USD
Slifka Eric
President & CEO
+ 100
26.26 USD
19 years ago
Oct 04, 2005
Bought 561 K USD
Slifka Eric
President and CEO
+ 25500
22 USD
19 years ago
Oct 04, 2005
Bought 273 K USD
Faneuil Edward J
Executive VP and GC
+ 12400
22 USD
19 years ago
Oct 04, 2005
Bought 110 K USD
Rudinsky Charles A
Sr. VP & Chief Accounting Off.
+ 5000
22 USD
19 years ago
Oct 04, 2005
Bought 48.1 K USD
McManmon Thomas A Jr
Executive VP and CFO
+ 2000
24.05 USD
19 years ago
Oct 04, 2005
Bought 638 K USD
McManmon Thomas A Jr
Executive VP and CFO
+ 29000
22 USD
7. News
GLP-1 makers could be under pressure in 2025 Jared Holz, Mizuho, joins 'Fast Money' to talk what is next for the obesity drug makers in 2025. youtube.com - 1 week ago
Cramer's Mad Dash: Cornell report on GLP-1s shows decrease in consumption of savory snacks CNBC's Jim Cramer reports on a study from Cornell and its impact on the stock market. youtube.com - 2 weeks ago
Should You Buy the Dip in Novo Nordisk Stock Right Now? The biggest talking point in the pharmaceutical industry at the moment revolves around treatments known as glucagon-like peptide-1 (GLP-1) agonists. GLP-1 agonists are used to treat diabetes and chronic weight management, although research suggests these medications could have other applications in areas such as sleep apnea, kidney disease, and cardiovascular complications. fool.com - 2 weeks ago
Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help recipients lose less weight than previously forecasted, BMO Capital Markets cut its price target on the pharmaceutical company from $156 to $105 per share. "This was supposed to be Novo's answer to Tirzepatide and Retatrutide, some higher efficacy drugs, and it kind of feels like where no man's land here. youtube.com - 3 weeks ago
Novo Nordisk Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory Deal Novo has handed Wolff one of the most complex jobs in all of pharmaceuticals. barrons.com - 1 month ago
Viking Therapeutics: Holiday Gift Viking Therapeutics has seen a significant drop, losing 50% in value since late October, despite positive news and promising GLP-1 drug developments. The biotech's oral GLP-1 candidate VK2735 showed impressive weight loss results and tolerability, with potential advantages over current weekly injectable treatments. Concerns about manufacturing costs and scalability exist, but Viking's strong pipeline and market potential in obesity make it a compelling investment. seekingalpha.com - 1 month ago
TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs BALTIMORE--(BUSINESS WIRE)---- $TNFA--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNFA” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune and inflammatory conditions, today announced that it has entered into a collaborative agreement with Renova Health for a planned trial of its TNF-alpha (TNF-α) inhibitor drug isomyosamine (MYMD-1) as a treatment for GLP-1-induced sarcopenia and frailty. The fully funded study is expected to evaluate. businesswire.com - 1 month ago
Lexaria's Registered GLP-1 Study #4 Begins Dosing Registered Phase-1b 12-week study will investigate safety, diabetes control, and weight loss KELOWNA, BC / ACCESSWIRE / December 19, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has begun dosing in the Company's Phase 1b, 12-week chronic study GLP-1-H24-4, (the "Study"). The Study is designed mainly to determine whether Lexaria's proprietary DehydraTECH technology improves the safety and effectiveness of existing GLP-1 drugs. accesswire.com - 1 month ago
Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative biopharmaceutical company developing novel, ultra long-acting drug implants, today announced that screening and enrollment of the first-in-human clinical trial, known as LIBERATE-1™, has been initiated at two centers in Australia to investigate the safety, tolerability and full pharmacokinetic profile of an exenatide implant. This study is the first clinical application of the Compan. businesswire.com - 1 month ago
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon Recent sales of a little-known stock, Madrigal Pharmaceuticals NASDAQ: MDGL, could bode well for Novo Nordisk A/S NYSE: NVO. The pharma industry giant has seen explosive sales growth for its GLP-1 agonist drug, semaglutide. marketbeat.com - 1 month ago
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial) BEIJING and BRIDGEWATER, N.J. , Dec. 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" FDA ") has cleared the Investigational New Drug (IND) application for GZR18 Injection to conduct a phase 2 clinical trial, a head-to-head with Tirzepatide from Eli Lilly and Company (NYSE: LLY) in the US (NCT06737042). prnewswire.com - 1 month ago
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe Successful Completion of All Planned Implants in GLP Study enVVe Delivery System Demonstrates Consistent Performance Company Maintains Timeline for IDE Application Submission by Mid-2025, Pending GLP Study Results IRVINE, CA / ACCESSWIRE / December 16, 2024 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced the successful completion of the final wave of implants for shorter-term subjects in its six-month pre-clinical GLP study for enVVe, its transcatheter-delivered replacement venous valve. The successful completion of all planned implants in the GLP study, including both long-term and short-term subjects, completes a critical phase of the study. accesswire.com - 1 month ago
8. Profile Summary

Global Partners LP GLP

image
COUNTRY US
INDUSTRY Oil & Gas Midstream
MARKET CAP $ 1.8 B
Dividend Yield 1.89%
Description Global Partners LP engages in the purchasing, selling, gathering, blending, storing, and logistics of transporting gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, and propane to wholesalers, retailers, and commercial customers in the New England states, Mid-Atlantic region, and New York. The company is also involved in the transportation of petroleum products and renewable fuels through rail from the mid-continent region of the United States and Canada. Its Wholesale segment sells home heating oil, branded and unbranded gasoline and gasoline blendstocks, diesel, kerosene, residual oil, and propane to home heating oil retailers and wholesale distributors. It also aggregates crude oil through truck or pipeline in the mid-continent region of the United States and Canada, as well as transports it through rail and ships it through barge to refiners. The company's Gasoline Distribution and Station Operations segment sells branded and unbranded gasoline to gasoline station operators and sub-jobbers; operates gasoline stations and convenience stores; and provides car wash, lottery, and ATM services, as well as leases gasoline stations. Its Commercial segment sells and delivers unbranded gasoline, home heating oil, diesel, kerosene, residual oil, and bunker fuel to customers in the public sector, as well as to commercial and industrial end-users; and sells custom blended fuels. As of December 31, 2021, the company had a portfolio of 1,595 owned, leased, and supplied gasoline stations, which included 295 directly operated convenience stores; and owned, leased, or maintained storage facilities at 26 bulk terminals with a collective storage capacity of 11.9 million barrels. Global GP LLC serves as the general partner of the company. The company was incorporated in 2005 and is based in Waltham, Massachusetts.
Contact 800 South Street, Waltham, MA, 02454-9161 https://www.globalp.com
IPO Date Sept. 29, 2005
Employees 3485
Officers Mr. Eric S. Slifka President, Chief Executive Officer & Vice Chairman of Global GP LLC Mr. Matthew Spencer Chief Accounting Officer of Global GP LLC Mr. Sean T. Geary Chief Legal Officer & Secretary Lorraine Spadaro Chief Information Officer Mr. Scott Solomon Vice President of Investor Relations Catie Kerns Vice President of Communications & SVP of Corporate Affairs Philip Segaloff Senior Associate General Counsel Mr. Gregory B. Hanson Chief Financial Officer of Global GP LLC Ms. Maura McDonough Chief People Officer Mr. Mark A. Romaine Chief Operating Officer of Global GP LLC